No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 3, 1996, Pages 268-275

  Galli, Massimo ^a   Musicco, Massimo ^b   Gervasoni, Cristina ^a   Ridolfo, Anna Lisa ^a   Niero, Fosca ^a   Rusconi, Stefano ^a   Riva, Agostino ^a   Voltolin, Luca ^a   Lupo, Angelica ^a   Lovicu, Gian Franco ^b   Radice, Davide ^b   Moroni, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

Author keywords

HIV 1; Progression to AIDS; Thrombocytopenia

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOIMMUNITY; DISEASE COURSE; FEMALE; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 1542534435     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199607000-00006     Document Type: Article

References (38)

1. Kaslow RA, Phair JP, Friedman HP, et al. Infection with the human immunodeficiency virus; clinical manifestations and their relationship to immunodeficiency. A report from the multicentre AIDS Cohort Study. Ann Intern Med 1987;107: 474-80.
2. Jost J, Tauber MG, Luthy R, Sieghentaler W. HIV-assozierte Thrombocytopenie. Schweiz Med Wochenschr 1988;118:206-12.
3. Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337-40.
4. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Res Hum Retrovir 1990;6:261-9.
5. Landonio G, Galli M, Nosari A, et al. HIV-1 related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up and pathogenetic evaluation. AIDS 1990;4:29-34.
6. Finazzi G, Mannucci PM, Lazzarin A, et al. Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and haemophiliacs: implication for therapeutic strategies. Eur J Haematol 1990;45:82-95.
7. Walsh CM, Nardi MA, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual man. N Engl J Med 1984;311:635-9.
8. Yu JR, Lennette ET, Karpatkin S. Anti-F(ab′) antibodies in thrombocytopenic purpura patients at risk for acquired immunodeficiency syndrome. J Clin Invest 1986;77:1756-61.
9. Karpatkin S, Nardi MA, Lennette ET, Byrne B, Polesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci USA 1988; 85:9763.
10. Van der Lelie J, Lange JMA, Voss JJE, et al. Autoimmunity against blood cells in human immunodeficiency virus (HIV) infection. Br J Haematol 1987;67:109-14.
11. Hohmann AW, Booth K, Peters V, Gordon DL, Comacchio DL. Common epitope on HIVp24 and human platelets. Lancet 1993;342:1274-5.
12. Bettaich A, Fromont P, Louache F, et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-1 related thrombocytopenic purpura. Blood 1992;80:162-9.
13. Flegg PJ, Jones ME, MacCallum LR, et al. Effect of zidovudine on platelet counts. Br Med J 1989;208:1074-5.
14. Hymes KB, Green JB, Karpatkin S. The effect of azidothimidine on HIV-related thrombocytopenia. N Engl J Med 1988;318:516-7.
15. The Swiss Group for Clinical Studies on AIDS. Zidovudine for the treatment of thrombocytopenia associated with HIV. Ann Intern Med 1989;110:365-8.
16. Oksenhendler E, Bierlin P, Ferchal F, Clauvel JP, Seligmann M. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;103:542-5.
17. Montaner JSG, Le T, Fanning M, et al. The effect of zidovudine on platelet counts in HIV-infected individuals. J Acquir Immune Defic Syndr 1990;3:565-70.
18. Ratner L. Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review. Am J Med 1989;86:194-8.
19. Walsh C, Krigel R, Lennette E, Karpatkin S. Thrombocytopenia in homosexual patients: prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:542-5.
20. Gordswerg HG, Grossman R, William D. Thrombocytopenia in homosexual men. Am J Haematol 1986;21:243-47.
21. Peltier JV, Lambin P, Doinel C, Couroucè AM, Rouger P, Lefrere JJ. Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: a five-year prospective study. AIDS 1991;5:381-4.
22. Abrams DI, Kiprov DD, Goedert JJ, et al. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med 1986;104:47-50.
23. Holzman RS, Walsh CM, Karpatkin S. Risk of the acquired immunodeficiency syndrome among thrombocytopenic and non-thrombocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med 1987;106: 383-6.
24. Cameron DA, Flegg PJ. The prognostic importance of thrombocytopenia. AIDS 1991;5:1266-7.
25. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl 1):1S-15S.
26. Sloand EM, Klein HG, Banks SM, Vareldris B, Merritt S, Pierce P. Epidemiology of thrombocytopenia in HIV infection. Eur J Hematol 1993;50:239-40.
27. Landonio G, Nosari A, Spinelli F, Vigorelli R, Caggese L, Schlacht I. HIV-related thrombocytopenia: four different clinical subsets. Haematologica 1992;77:398-401.
28. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992;327: 1812-3.
29. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med 1994;123:415-20.
30. Spivak JL, Stuart ES, Thomas CQ. Acquired immune deficiency syndrome and pancytoponia. JAMA 1983;250: 3084-7.
31. Zucker-Franklin D, Cao Y. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Prot Natl Acad Sci USA 1989;86:5595-9.
32. Zucker-Franklin D, Seremetis S, Zheng ZY. Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. Blood 1990;75: 1920-3.
33. +) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992;79:2680-7.
34. Kunzi MS, Groopman JE. Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. Blood 1993;81:3336-12.
35. Mientjes GHC, Van Ameijden EJC, Mulder JW, Van den Hoek JAR, Coutinho RA, Von dem Borne AE. Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men. Br J Haematol 1992;82: 615-9.
36. Adams WH, Rufo RA, Talarico L, Silverman SL, Brauer MJ. Thrombocytopenia and intravenous heroin use. Ann Intern Med 1978;89:207-11.
37. Koury MJ. Thrombocytopenic purpura in HIV seronegative users of intravenous cocaine. Am J Hematol 1990;35:134-5.
38. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JI. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immuno-deficiency virus. J Acquir Immune Defic Syndr 1993;6:602-10.